Right To Try Laws

Meeting review of unique stem cell ethics symposium @UCDAVIS

Stem-cell-ethics-meeting-e1479769073498

On Thursday here at UC Davis School of Medicine we held our second annual Stem Cell Ethics Symposium. The symposium was organized by Drs. Mark Yarborough and Nanette Joyce as well as me. In this post I report on key take homes from the meeting and summarize the specific talks. As far as I know, this is one of the few …

Meeting review of unique stem cell ethics symposium @UCDAVIS Read More »

New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Research

FDA3

It’s been a seemingly rather quiet year on the regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank the …

New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »

Interview with Neuralstem CEO Richard Garr

I invited Neuralstem CEO, Richard Garr, to do a Q&A interview and he kindly accepted. The interview provides some novel insights into this major biotech in the stem cell sector. 1. How is Neuralstem doing today? What programs are underway that you find particularly exciting?  Garr: Neuralstem is moving on all cylinders these days on …

Interview with Neuralstem CEO Richard Garr Read More »

Key questions for stem cell field bouncing around on a Friday morning

ViaCyte-New-Logo

What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at the moment in no particular order. You can see a lot of translational/clinical things are on my mind. I’ve …

Key questions for stem cell field bouncing around on a Friday morning Read More »